Aficamten was associated with improved peak oxygen uptake and a tolerable safety profile vs. metoprolol, a beta-blocker, in ...

Topline results were released from the phase 3 MAPLE-HCM trial, which compared aficamten with metoprolol in 175 adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). The ...

An Oklahoma cardiologist had a full circle moment when a Dutch man complained of chest pains on their shared flight to ...

Pharmaceuticals are among the most tested, analyzed and scrutinized consumer products in the world. Initial laboratory ...

Discover 7 treatments for ischemic heart disease that are saving lives. From cutting-edge medications to advanced procedures ...

Cytokinetics has shared positive top-line results from a late-stage study of its investigational oral cardiac myosin inhibitor aficamten in hypertrophic cardiomyopathy (HCM). The phase 3 MAPLE-HCM ...

In October 2020 came a breakthrough: the NHS agreed to genotype all people who were due to receive the drug. Since then, about 45,000 people a year have been tested. “If they’ve got one of these ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Maack et al. [70] recently reported on switching between β blockers (metoprolol and carvedilol) in 68 patients treated with either agent for 1 year who had improved in terms of LVEF and NYHA class.

Available in blister packs 30 tablets. MINAX XL contains 23.75 mg, 47.5 mg, 95 mg or 190 mg of metoprolol succinate as the active ingredient.

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 84 new drugs including various anti-hypertension, anti-diabetic, anti-inflammatory drug combinations in a latest ...

If there is one migraine truth that I wish everyone understood, it is this: Migraine is much, much more than a headache.